Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
Zoetis (ZTS) Closes 86.1M IPO; Pfizer (PFE) Remains 80% Owner
-
Pfizer's Zoetis (ZTS) Sees IPO Price of $22 - $25/Share
-
Notable Analyst Rating Changes 11/27: (EXC) (YELP) (NOK) Upgraded; (PFE) (MMR) (NOV) Downgraded
-
Notable Analyst Rating Changes 04/10: (HOG) (DELL) (AIG) Upgraded; (ALTH) (FHN) (JEC) Downgraded
-
Morning Movers 07/20: (NLC) (TESS) (QPSA) (IDCC) Higher; (ICGN) (RVBD) (FTNT) (CTRN) Lower
-
Morning Movers 06/20: (HRBN) (ACUR) (DEXO) (ANX) Higher; (APWR) (CTFO) (CNTF) (HAFC) Lower
-
Morning Movers 09/23: BNVID, TESS, TSTR, ICGND, BXC, TIV, EW, SIFY Higher; RAD, CPRT Lower
-
Piper Jaffray Initiates Coverage on Rigel Pharmaceuticals (RIGL) with an Overweight; Investor Apathy Creates Unique Opportunity
-
Unusual 11 Mid-Day Movers 3/3: SWWC, TTPA, UFPT, NOVL, AMCF Higher; MDVN, VISN, CT, ARCL Lower
-
Morning Movers 3/3: SWWC, TTPA, NOVL, AMCF, UFPT, ETH Higher; MDVN, VISN, CT, RHB Lower
-
Notable Analyst Rating Changes 10/19: AXP, NOV, EL, DKS Upgrade; FNM/FRE, ANF, MAT, LUV Downgrade
-
Notable Analyst Rating Changes 8/17: WMT, BBT, IT, AN, N Upgraded; BJ, UBET, PSA Downgraded
-
Piper Jaffray Initiates Coverage on Johnson & Johnson (JNJ) with a Neutral; Moderate Upside Potential for Steady Performer
-
Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook
-
Notable Analyst Rating Changes 11/07: ANF, TWTC, CECEO Upgraded; TM, DLB, SI Downgraded
-
David Moenning's Daily State of the Markets: 7/23
-
Piper Jaffray Downgrades MannKind (MNKD) to Neutral; Slashes PT from $19 to $1.50
-
Notable Analyst Rating Changes 4/9: ZZ, GTI, CNQ Upgraded; CRM, COCO, NKTR, MNKD Downgraded
